Physician profile
Tana Bock
NPI 1528409505
$845.08
in general payments reported to CMS, 2019-2025
8 companies · $622 in 2025
The $622 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.29 · 2022: $55.79 · 2023: $36.35 · 2024: $77.58 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711 · Education: $24.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $711.27 |
| Education | $24.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $519.69 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Micra |
| Biosense Webster, INC. | $191.91 | 2024-2025 | Carto 3, Soundstar |
| Abbott Laboratories | $42.46 | 2021-2025 | Perclose Prostyle |
| Boston Scientific Corporation | $32.04 | 2024 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd |
| Cardiva Medical, INC. | $22.64 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abiomed | $18.91 | 2025 | |
| W. L. Gore & Associates, INC. | $12.22 | 2021 | |
| Cardiovascular Systems INC. | $5.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tana Bock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.